Steward Partners Investment Advisory’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,146
| Closed | -$4.44K | – | 3603 |
|
|
2023
Q3 | $4.44K | Hold |
4,146
| – | – | ﹤0.01% | 2867 |
|
|
2023
Q2 | $10.7K | Sell |
4,146
-4,817
| -54% | -$12.5K | ﹤0.01% | 2547 |
|
|
2023
Q1 | $36.6K | Hold |
8,963
| – | – | ﹤0.01% | 1990 |
|
|
2022
Q4 | $45K | Buy |
8,963
+951
| +12% | +$4.77K | ﹤0.01% | 1878 |
|
|
2022
Q3 | $105K | Buy |
8,012
+3,195
| +66% | +$41.9K | ﹤0.01% | 1477 |
|
|
2022
Q2 | $62K | Buy |
4,817
+2,800
| +139% | +$36K | ﹤0.01% | 1701 |
|
|
2022
Q1 | $31K | Buy |
+2,017
| New | +$31K | ﹤0.01% | 2164 |
|
|
2021
Q4 | – | Sell |
-2,000
| Closed | -$42K | – | 3355 |
|
|
2021
Q3 | $42K | Hold |
2,000
| – | – | ﹤0.01% | 1987 |
|
|
2021
Q2 | $39K | Hold |
2,000
| – | – | ﹤0.01% | 3822 |
|
|
2021
Q1 | $58.1K | Buy |
+2,000
| New | +$58.1K | ﹤0.01% | 1904 |
|